Dynamic reduction of plasma decorin following ischemic stroke: A pilot study

Neurochemical Research

Volumn 37, Issue 9, 2012, Pages 1843-1848

  Xu, Yuan Zhi ^a   Yang, Zhi Gang ^a   Zhang, Yu Hui ^a   Zhang, Yong Wei ^a   Hong, Bo ^a   Liu, Jian Min ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Decorin; Extracellular matrix remodeling; Stroke

Indexed keywords

DECORIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DECORIN BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE MARKER; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; BRAIN ISCHEMIA; DECORIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 84866741845     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0787-0     Document Type: Article

References (25)

1. Truelsen T, Heuschmann PU, Bonita R et al (2007) Standard method for developing stroke registers in low-income and middle income countries: experiences from a feasibility study of a stepwise approach to stroke surveillance (STEPS Stroke). Lancet Neurol 6(2):134-139
2. Saenger AK, Christenson RH (2010) Biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin Chem 56(1):21-33
3. Chen S, Brik DE (2011) Focus on molecules: decorin. Exp Eye Res 92(6):444-445
4. Schaefer L, Iozzo RV (2008) Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 283(31):21305-21309
5. Iozzo RV, Moscatello DK, McQuillan DJ, Eichstetter I (1999) Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 274:4489-4492
6. Schonherr E, Sunderkotter C, Iozzo RV, Schaefer L (2005) Decorin, a novel player in the insulin-like growth factor system. J Biol Chem 280:15767-15772
7. Kresse H, Schonherr E (2001) Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 189:266-274
8. Merle B, Durussel L, Delmas PD, Clezardin P (1999) Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain. J Cell Biochem 75:538-546
9. Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35-41
10. Bamford JM, Sandercock PA, Warlow CP, Slattery J (1989) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 20(6):828
11. Chen J, Yu H, Sun K et al (2010) Promoter variant of angiopoietin- 2 and plasma angiopoietin-2 are associated with risk of stroke recurrence in lacunar infarct patients. Biochem Biophys Res Commun 398(2):212-216
12. Al Haj Zen A, Caligiuri G, Sainz J et al (2006) Decorin overexpression reduces atherosclerosis development in apolipoprotein E-deficient mice. Atherosclerosis 187(1):31-39
13. Yamaguchi Y, Mann DM, Ruoslahti E (1990) Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346:281-284
14. Huang J, Upadhyay UM, Tamargo RJ (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66(3):232-245
15. Lehrmann E, Kiefer R, Finsen B et al (1995) Cytokines in cerebral ischemia: expression of transforming growth factor beta-1 (TGF-beta 1) mRNA in the postischemic adult rat hippocampus. Exp Neurol 131:114-123
16. Wiessner C, Gehrmann J, Lindholm D et al (1993) Expression of transforming growth factor-beta 1 and interleukin-1 beta mRNA in rat brain following transient forebrain ischemia. Acta Neuropathol (Berl) 86:439-446
17. Wang ZQ, Wu DC, Huang FP, Yang GY (2004) Inhibition of MEK/ERK 1 and 2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia. Brain Res 996:55-66
18. Baumann E, Preston E, Slinn J, Stanimirovic D (2009) Postischemic hypothermia attenuates loss of the vascular basement membrane proteins, agrin and SPARC, and the blood-brain barrier disruption after global cerebral ischemia. Brain Res 7(1269):185-197
19. Schachtrup C, Ryu JK, Helmrick MJ et al (2010) Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage. J Neurosci 30(17): 5843-5854
20. Tagaya M, Haring HP, Stuiver I et al (2001) Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J Cereb Blood Flow Metab 21(7):835-846
21. Fukuda S, Fini CA, Mabuchi T et al (2004) Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 35(4):998-1004
22. Baeten KM, Akassoglou K (2011) Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke. Dev Neurobiol 71(11):1018-1039
23. Dong FQ, Li H, Wu F, Yao HP (2008) Effects of overexpression of decorin on matrix metalloproteinases 2 and 9 in rat mesangial and tubular cells. Zhonghua Yi Xue Za Zhi 88(48):3444-3447
24. Al Haj Zen A, Lafont A, Durand E et al (2003) Effect of adenovirus- mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts. Matrix Biol 22(3):251-258
25. Bäck M, Ketelhuth DF, Agewall S (2010) Matrix metalloproteinases in atherothrombosis. Prog Cardiovasc Dis 52(5):410-428